We are live on ! Find out more
EVH icon

Evolent Health

240 hedge funds and large institutions have $3.62B invested in Evolent Health in 2023 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 88 increasing their positions, 72 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more capital inflows, than outflows

Capital inflows: $744M | Capital outflows: $313M

30% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 33

22% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 72

4% more funds holding

Funds holding: 231 → 240 (+9)

3.51% more ownership

Funds ownership: 97.19% → 100.7% (+3.5%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

57% less call options, than puts

Call options by funds: $3.01M | Put options by funds: $6.96M

Holders
240
Holders Change
+9
Holders Change %
+3.9%
% of All Funds
3.81%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
43
Increased
88
Reduced
72
Closed
33
Calls
$3.01​M
Puts
$6.96​M
Net Calls
-⁠$3.95​M
Net Calls Change
-⁠$9.16​M

EVH Hedge Fund Activity: Q1 2023 in Review

240 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2023, worth a combined $3.62B — up 31% from $2.76B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new EVH positions and 33 closed out — a net gain of 10 holders — while 88 added to existing stakes and 72 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $316M. The largest seller was Point72 Asset Management, cutting an estimated $93.7M.

  • 240 institutional investors held Evolent Health (EVH) as of Q1 2023, up from 231 in Q4 2022.
  • Funds reported $3.62B of Evolent Health stock for Q1 2023, up 31% quarter-over-quarter.
  • 43 funds opened new Evolent Health positions in Q1 2023 and 33 closed out, a net change of +10 holders.
  • The largest Evolent Health buyer in Q1 2023 was Fidelity Investments, an estimated $316M added.
  • The largest Evolent Health seller in Q1 2023 was Point72 Asset Management, an estimated $93.7M sold.

Based on aggregated 13F filings for Q1 2023.